Apraclonidine 0.5% Ophth Sol 10ml
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is for eye use only.
Administration Instructions
1. Remove your contact lenses before using this medication. You can put them back in 15 minutes after administration, unless your eyes are irritated or infected.
2. Avoid touching the container tip to your eye, eyelid, or surrounding skin, as this can introduce bacteria into the medication and potentially cause severe eye problems or vision loss.
3. Tilt your head back and gently drop the medication into your eye.
4. If you are using multiple medications in the same eye, administer each one at least 5 minutes apart.
Storage and Disposal
Store this medication at room temperature, away from light and freezing temperatures. Keep all medications in a safe location, out of the reach of children and pets.
Missed Dose Instructions
If you miss a dose, use it as soon as you remember. However, if it is close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not use two doses at the same time or take extra doses.
Lifestyle & Tips
- Do not touch the dropper tip to any surface, including your eye, to avoid contamination.
- Wash hands thoroughly before and after using eye drops.
- If using other eye drops, wait at least 5 minutes between applications.
- Remove contact lenses before instilling drops and wait at least 15 minutes before reinserting them.
- Be aware of potential for drowsiness or dizziness, especially when starting treatment; avoid driving or operating machinery if affected.
- Report any new or worsening eye symptoms, or systemic side effects, to your doctor.
Available Forms & Alternatives
Available Strengths:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Changes in eyesight, eye pain, or severe eye irritation
Eyelid swelling
Eye discharge
Feeling that something is in the eye
Other Possible Side Effects
As with all medications, some people may experience side effects. Although many individuals have no side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other unusual symptoms that bother you or persist, contact your doctor for guidance:
Blurred eyesight
Eye irritation
Dry eyes
Dry mouth
Excessive tearing
* Dizziness or drowsiness
Reporting Side Effects
This list is not exhaustive, and you may experience other side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe eye pain or discomfort
- Significant eye redness or irritation that worsens
- Swelling of eyelids or around the eye
- Blurred vision or vision changes
- Signs of allergic reaction (e.g., severe itching, rash, hives, difficulty breathing)
- Excessive drowsiness or dizziness
- Very slow heart rate or feeling faint
Before Using This Medicine
Any allergies you have, including allergies to this drug, its components, or other substances, such as foods or medications. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are currently taking certain medications for depression, including isocarboxazid, phenelzine, or tranylcypromine, or medications for Parkinson's disease, such as selegiline or rasagiline.
If you are taking linezolid or methylene blue, as these medications may interact with this drug.
Please note that this is not an exhaustive list of all potential drug interactions or health problems that may be relevant to your treatment with this medication. Therefore, it is crucial to inform your doctor and pharmacist about all your medications, including:
Prescription and over-the-counter (OTC) medications
Natural products
Vitamins
Your doctor and pharmacist will help you determine whether it is safe to take this medication with your existing medications and health conditions. Do not initiate, discontinue, or modify the dose of any medication without first consulting your doctor to ensure your safety.
Precautions & Cautions
Before operating a vehicle or engaging in any activity that requires alertness and clear vision, wait until you understand how this drug affects you.
Do not exceed the prescribed duration of treatment, and only use this medication for the length of time specified by your doctor.
Regularly schedule check-ups with your doctor to monitor your eye pressure and vision, as advised.
Prior to consuming alcohol, marijuana, or other cannabis products, or taking prescription or over-the-counter medications that may impair your reactions, consult with your doctor.
If you are pregnant, planning to become pregnant, or are breastfeeding, discuss the potential benefits and risks of this medication with your doctor to determine the best course of action for you and your baby.
Overdose Information
Overdose Symptoms:
- Bradycardia (slow heart rate)
- Hypotension (low blood pressure)
- Somnolence (drowsiness)
- Lethargy
- Sedation
- Miosis (constricted pupils)
- Hypothermia
- Respiratory depression
- Apnea (especially in infants/children)
What to Do:
Seek immediate medical attention. Call 911 or your local emergency number. For poison control, call 1-800-222-1222. Treatment is supportive and symptomatic; maintain airway, breathing, and circulation. Atropine may be considered for bradycardia.
Drug Interactions
Major Interactions
- Monoamine Oxidase Inhibitors (MAOIs): Potential for enhanced hypotensive effects and/or CNS depression. Use with extreme caution or avoid.
- Tricyclic Antidepressants (TCAs): May blunt the hypotensive effect of apraclonidine.
Moderate Interactions
- CNS Depressants (e.g., alcohol, barbiturates, opioids, sedatives, anesthetics): Additive or potentiated CNS depressant effects (e.g., somnolence, dizziness).
- Cardiovascular Medications (e.g., beta-blockers, calcium channel blockers, cardiac glycosides, other antihypertensives): Potential for additive hypotensive or bradycardic effects.
- Other Alpha-Adrenergic Agonists (e.g., oral clonidine): Potential for additive systemic effects (e.g., hypotension, bradycardia, sedation).
Monitoring
Baseline Monitoring
Rationale: To establish baseline and assess efficacy of treatment.
Timing: Prior to initiation of therapy.
Rationale: To assess overall ocular health and identify any pre-existing conditions.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Regularly, as determined by ophthalmologist (e.g., at follow-up visits, after laser surgery).
Target: Individualized target IOP.
Action Threshold: If IOP is not adequately controlled or if there is a significant increase.
Frequency: At each follow-up visit and patient self-monitoring.
Target: Absence of severe or intolerable symptoms.
Action Threshold: If symptoms are severe, persistent, or indicate allergic reaction.
Frequency: At each follow-up visit and patient self-monitoring.
Target: Absence of severe or intolerable symptoms.
Action Threshold: If symptoms are severe, persistent, or impact quality of life.
Symptom Monitoring
- Ocular discomfort
- Ocular itching
- Ocular hyperemia (redness)
- Dry mouth
- Somnolence (drowsiness)
- Dizziness
- Fatigue
- Headache
- Bradycardia (slow heart rate)
- Hypotension (low blood pressure)
- Allergic conjunctivitis (ocular itching, redness, lid edema)
Special Patient Groups
Pregnancy
Category C. Animal studies have shown adverse effects on the fetus, but there are no adequate and well-controlled studies in pregnant women. Use only if the potential benefit justifies the potential risk to the fetus.
Trimester-Specific Risks:
Lactation
L3 (Moderately Safe). It is not known whether apraclonidine is excreted in human milk. Due to the potential for serious adverse reactions in nursing infants from alpha-2 adrenergic agonists, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Minimal systemic absorption suggests low risk, but caution is advised.
Pediatric Use
Safety and efficacy have not been established in pediatric patients. Use in children, especially infants, is generally not recommended due to the potential for serious systemic adverse effects such as bradycardia, hypotension, and somnolence, which can lead to apnea. If used, extreme caution and close monitoring are required.
Geriatric Use
No overall differences in safety or effectiveness have been observed between elderly and younger patients. However, elderly patients may be more susceptible to systemic adverse effects (e.g., dizziness, somnolence, dry mouth) due to potential for increased sensitivity or comorbidities. Use with caution and monitor for systemic effects.
Clinical Information
Clinical Pearls
- Apraclonidine is primarily used for short-term IOP control, especially around laser surgery, or as adjunctive therapy for glaucoma due to the potential for tachyphylaxis (diminished response over time) with long-term use.
- Patients may develop an allergic-like reaction (ocular itching, hyperemia, lid edema) with chronic use, which can necessitate discontinuation.
- Systemic side effects like dry mouth, somnolence, and dizziness are common, even with ophthalmic administration, due to some systemic absorption.
- Caution is advised in patients with severe cardiovascular disease, renal impairment, or cerebrovascular disease due to potential for systemic effects.
- Educate patients on proper instillation technique to minimize systemic absorption and maximize local effect.
Alternative Therapies
- Beta-blockers (e.g., timolol, betaxolol)
- Prostaglandin analogs (e.g., latanoprost, travoprost, bimatoprost)
- Carbonic anhydrase inhibitors (e.g., dorzolamide, brinzolamide)
- Alpha-adrenergic agonists (e.g., brimonidine - another alpha-2 agonist, often preferred for long-term use over apraclonidine due to less tachyphylaxis)
- Rho kinase inhibitors (e.g., netarsudil)
- Cholinergic agonists (e.g., pilocarpine)
- Combination products (e.g., timolol/dorzolamide, timolol/brimonidine)